$22.12
0.25[1.14%]
At close: Apr 26
$22.12
0[0.00%]
After Hours: 4:20PM EDT
Arrowhead Pharma
(NASDAQ:ARWR)Arrowhead Pharma Stock (NASDAQ:ARWR), Insider Trading Activity
Arrowhead Pharma: Insider buying and selling updated today.
Insider Shares Owned
7.796M
Insider Percentage Owned
6.29%
Institutional Shares Held
61.868M
Institutional Percentage Held
49.9%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 03, 2024 | James Hamilton | CHIEF DISCOVERY/TRANS MEDICINE | -6K | $28.03 | -$168.18K | SELL | -2.85% | 204.851K | Apr 01 | View |
| Mar 20, 2024 | Hongbo Lu | DIRECTOR | 3K | $27.66 | $82.99K | BUY | 9.78% | 33.68K | Mar 18 - Mar 20 | View |
| Mar 08, 2024 | Kenneth Myszkowski | CHIEF FINANCIAL OFFICER | -40K | $35.19 | -$1.41M | SELL | -9.08% | 400.6K | Mar 06 | View |
| Feb 02, 2024 | Christopher Anzalone | CHIEF EXECUTIVE OFFICER | 0 | $23.44 | -$1.02M | SELL-OPTIONS | 0.00% | 3.715048M | Jan 31 | View |
| Jan 17, 2024 | James Hamilton | CHIEF DISCOVERY/TRANS MEDICINE | -7.94K | $36.89 | -$292.90K | SELL | -3.63% | 210.851K | Jan 12 | View |
| Jan 16, 2024 | Douglass Given | DIRECTOR | -2.911K | $38.06 | -$110.79K | SELL | -2.19% | 129.711K | Jan 11 | View |
| Jan 16, 2024 | William Waddill | DIRECTOR | -3.934K | $38.07 | -$149.76K | SELL | -7.59% | 47.87K | Jan 11 | View |
| Jan 16, 2024 | Mauro Ferrari | DIRECTOR | -3.147K | $38.06 | -$119.79K | SELL | -4.92% | 60.778K | Jan 11 | View |
| Jan 16, 2024 | Victoria Vakiener | DIRECTOR | -4.72K | $38.10 | -$179.81K | SELL | -12.85% | 32.001K | Jan 11 | View |
| Jan 08, 2024 | Tracie Oliver | CHIEF COMMERCIAL OFFICER | 74.926K | $33.89 | -$2.51K | GRANT | 121.68% | 136.501K | Jan 04 - Jan 05 | View |
| Jan 08, 2024 | Kenneth Myszkowski | CHIEF FINANCIAL OFFICER | 58.896K | $35.27 | -$567.91K | GRANT | 15.43% | 440.6K | Jan 04 - Jan 05 | View |
| Jan 08, 2024 | Javier San Martin | CHIEF MEDICAL OFFICER | 66.697K | $35.26 | -$292.80K | GRANT | 50.60% | 198.497K | Jan 04 - Jan 05 | View |
| Jan 05, 2024 | James Hamilton | 36.557K | $34.69 | -$1.33M | GRANT | 20.06% | 218.791K | Jan 03 - Jan 05 | View | |
| Jan 05, 2024 | Patrick O'Brien | COO AND GENERAL COUNSEL | 51.81K | $34.36 | -$1.14M | GRANT | 12.56% | 464.385K | Jan 03 - Jan 05 | View |
| Jan 04, 2024 | Christopher Anzalone | CHIEF EXECUTIVE OFFICER | -9.952K | $31.01 | -$308.64K | SELL | -0.27% | 3.715048M | Jan 02 | View |
| Dec 22, 2023 | Christopher Anzalone | CHIEF EXECUTIVE OFFICER | -12K | $28.54 | -$342.48K | SELL | -0.32% | 3.725M | Dec 20 | View |
| Nov 22, 2023 | Javier San Martin | CHIEF MEDICAL OFFICER | -19.7K | $28.80 | -$567.32K | SELL | -13.00% | 131.8K | Nov 20 | View |
| Oct 27, 2023 | Christopher Anzalone | CHIEF EXECUTIVE OFFICER | -24.338K | $24.21 | -$589.22K | SELL | -0.65% | 3.737M | Oct 25 | View |
| Oct 02, 2023 | Victoria Vakiener | DIRECTOR | -1.55K | $26.33 | -$40.81K | SELL | -6.66% | 21.734K | Sep 28 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.